Vimarsana.com

Latest Breaking News On - Cumberland pharmaceuticals - Page 6 : vimarsana.com

NCCN Senior Director Evelyn Handel Zapata is Named a '40 Under 40 in Cancer: Emerging Leader' for Milestone Work Improving Safe Use of Chemotherapy

NCCN Senior Director Evelyn Handel Zapata is Named a '40 Under 40 in Cancer: Emerging Leader' for Milestone Work Improving Safe Use of Chemotherapy
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Chicago
Illinois
United-states
America
Handel-zapata
Robertw-carlson
Prnewswire-evelyn-handelzapata
Rachel-darwin
National-comprehensive-cancer-network
Patient-education-committee
Cumberland-pharmaceuticals
Pharmacy-directors-forum

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Crosses Above 200-Day Moving Average of $1.73

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.73 and traded as high as $2.25. Cumberland Pharmaceuticals shares last traded at $2.24, with a volume of 38,916 shares changing hands. […]

United-states
Nasdaq
News-ratings-for-cumberland-pharmaceuticals-daily
Cumberland-pharmaceuticals-trading
Cumberland-pharmaceuticals
Renaissance-technologies
Institutional-investors-weigh-in-on-cumberland-pharmaceuticals
Millennium-management
Cumberland-pharmaceuticals-inc
Acadian-asset-management
B-riley-wealth-advisors-inc

StockNews.com Initiates Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX)

StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report published on Wednesday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Price Performance Shares of NASDAQ:CPIX opened at $1.92 on Wednesday. The firm has a market cap of $27.59 million, a PE ratio of […]

United-states
News-ratings-for-cumberland-pharmaceuticals-daily
Cumberland-pharmaceuticals-company-profile
Nasdaq
B-riley-wealth-advisors-inc
Cumberland-pharmaceuticals-price-performance
Millennium-management
Acadian-asset-management
Cumberland-pharmaceuticals-inc
Cumberland-pharmaceuticals
Institutional-investors-weigh-in-on-cumberland-pharmaceuticals

StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX)

StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report published on Wednesday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Trading Up 3.8 % NASDAQ:CPIX opened at $1.92 on Wednesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.62 […]

United-states
Cumberland-pharmaceuticals-inc
Nasdaq
Millennium-management
Acadian-asset-management
News-ratings-for-cumberland-pharmaceuticals-daily
Cumberland-pharmaceuticals-trading
B-riley-wealth-advisors-inc
Renaissance-technologies
Cumberland-pharmaceuticals
Free-report

Antimicrobial Resistance Market to Reach $9.5 Billion, Globally, by 2032 at 7.6% CAGR: Allied Market Research

/PRNewswire/ -- Allied Market Research published a report, titled, "Antimicrobial Resistance Market By Drug Class (Combination Therapies, Tetracyclines,...

Hong-kong
China
Portland
Oregon
United-states
India
Pune
Maharashtra
United-kingdom
America
David-correa
Pawan-kumar

Analysts' New Coverage for September 13th (AACG, AAME, ACRE, ADXS, AEY, AKTX, AMED, AP, APWC, ARNC)

Analysts’ new coverage for Wednesday, September 13th: StockNews.com assumed coverage on shares of ATA Creativity Global (NASDAQ:AACG). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. Wells Fargo & Company began coverage on shares of Ares Commercial Real […]

Chile
Xinyuan
Sichuan
China
United-states
American
William-blair
Roth-mkm
Janney-montgomery-scott
Societe-generale
Beasley-broadcast-group
Jpmorgan-chase-co

Cumberland Pharmaceuticals (CPIX) Enters New $25M Revolving Credit Facility

Cumberland Pharmaceuticals (CPIX) Enters New $25M Revolving Credit Facility
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cumberland-pharmaceuticals
Pinnacle-bank-the-new-agreement
Revolving-credit-loan-agreement
Pinnacle-bank
New-pinnacle-agreement
Funded-debt-ratio

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Short Interest Update

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 19,100 shares, an increase of 6.1% from the July 31st total of 18,000 shares. Approximately 0.2% of the shares of the company are […]

Institutional-investors-weigh-in-on-cumberland-pharmaceuticals
Cumberland-pharmaceuticals-company-profile
B-riley-wealth-advisors-inc
Millennium-management
Cumberland-pharmaceuticals-stock-performance
Cumberland-pharmaceuticals-inc
Acadian-asset-management
Renaissance-technologies
News-ratings-for-cumberland-pharmaceuticals-daily
Cumberland-pharmaceuticals
Nasdaq

Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Stock Up 1.8 % Shares of CPIX stock opened at $1.68 on Friday. The company has a debt-to-equity ratio of […]

B-riley-wealth-advisors-inc
Institutional-trading-of-cumberland-pharmaceuticals
Cumberland-pharmaceuticals
Renaissance-technologies
News-ratings-for-cumberland-pharmaceuticals-daily
Acadian-asset-management
Cumberland-pharmaceuticals-stock
Cumberland-pharmaceuticals-inc
Millennium-management
Free-report
Capital-management

vimarsana © 2020. All Rights Reserved.